View : 37 Download: 8

Early response to bortezomib combined chemotherapy can help predict survival in patients with multiple myeloma who are ineligible for stem cell transplantation

Title
Early response to bortezomib combined chemotherapy can help predict survival in patients with multiple myeloma who are ineligible for stem cell transplantation
Authors
Lee H.S.Kim Y.S.Kim K.Kim J.S.Kim H.J.Min C.-K.Suh C.Eom H.-S.Yoon S.-S.Lee J.H.Kim M.K.Kim S.-H.Bae S.H.Mun Y.-C.Jo D.Y.Chung J.-S.
Ewha Authors
문영철
SCOPUS Author ID
문영철scopus
Issue Date
2013
Journal Title
Journal of Korean Medical Science
ISSN
1011-8934JCR Link
Citation
vol. 28, no. 1, pp. 80 - 86
Indexed
SCI; SCIE; SCOPUS; KCI WOS scopus
Abstract
Novel agents to treat multiple myeloma (MM) have increased complete respone (CR) rates compared with conventional chemotherapy, and the quality of the response to treatment has been correlated with survival. The purpose of our study was to show how of early response to bortezomib combined chemotherapy influences survival in patients with newly diagnosed MM who are ineligible for stem cell transplantation. We assessed patient responses to at least four cycles of bortezomib using the International Myeloma Working Group response criteria. The endpoints were comparisons of progression free survival (PFS) and overall survival (OS) between early good response group (A group) and poor response group (B group). We retrospectively analyzed data from 129 patients registered by the Korean Multiple Myeloma Working Party, a nationwide registration of MM patients. The 3 yr PFS for the A and B groups was 55.6% and 18.4%, respectively (P < 0.001). The 3 yr OS for the A and B groups was 65.3% and 52.9%, respectively (P = 0.078). The early response to at least four cycle of bortezomib before next chemotherapy may help predict PFS in patients with MM who are ineligible stem cell transplantation. © 2013 The Korean Academy of Medical Sciences.
DOI
10.3346/jkms.2013.28.1.80
Appears in Collections:
의과대학 > 의학과 > Journal papers
Files in This Item:
001.pdf(530.8 kB)Download
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE